Pharma News

ISPE Good Practice Guide: Technology Transfer 3rd Edition Released

  • Posted on: 22 January 2019
  • By: Shalini.Sharma

The International Society for Pharmaceutical Engineering (ISPE) ISPE announced the release of their latest Guide, ISPE Good Practice Guide: Technology Transfer 3rd Edition. This Guide provides industry good practices for successful and efficient execution of technology transfer projects.

Indian firms recall drugs in US market

  • Posted on: 22 January 2019
  • By: Shalini.Sharma

INDIAN DRUG majors Lupin, Sun Pharma and Glenmark Pharmaceuticals are recalling various drugs from the US market for a variety of reasons.

FDA unprecedented new efforts to support development of over-the-counter naloxone to help reduce opioid overdose deaths

  • Posted on: 18 January 2019
  • By: Shalini.Sharma

The  number of overdose deaths involving prescription and illicit opioids more than doubling over the last seven years to nearly 48,000 in 2017.  This includes new ways to increase availability of naloxone, a drug used to treat opioid overdose.

New Findings Reveal Surprising Role of the Cerebellum in Reward and Social Behaviors: NIH

  • Posted on: 18 January 2019
  • By: Shalini.Sharma

A new study in rodents has shown that the brain’s cerebellum—known to play a role in motor coordination—also helps control the brain’s reward circuitry. Researchers found a direct neural connection from the cerebellum to the ventral tegmental area (VTA) of the brain, which is an area long known to been involved in reward processing and encoding. These findings, published in Science, demonstrate for the first time that the brain’s cerebellum plays a role in controlling reward and social preference behavior, and sheds new light on the brain circuits critical to the affective and social dysfunction seen across multiple psychiatric disorders. The research was funded by the National Institute of Mental Health (NIMH), part of the National Institutes of Health.

FICCI welcomes government's move to accord 'industry status' to hospitals

  • Posted on: 17 January 2019
  • By: Shalini.Sharma

The Federation of Indian Chambers of Commerce and Industry (FICCI) has welcomed the Government's announcement of according 'industry status' to private hospitals, along with support for land acquisition, clearances and funding, to boost expansion of healthcare infrastructure in tier 2 and 3 cities.

NIH researchers rescue photoreceptors, prevent blindness in animal models of retinal degeneration

  • Posted on: 17 January 2019
  • By: Shalini.Sharma

Using a novel patient-specific stem cell-based therapy, researchers at the National Eye Institute (NEI) prevented blindness in animal models of geographic atrophy, the advanced "dry" form of age-related macular degeneration (AMD), which is a leading cause of vision loss among people age 65 and older. The protocols established by the animal study, published January 16 in Science Translational Medicine (STM), set the stage for a first-in-human clinical trial testing the therapy in people with geographic atrophy, for which there is currently no treatment.

FDA approves first generic version of Sabril to help treat seizures in adults and pediatric patients with epilepsy

  • Posted on: 17 January 2019
  • By: Shalini.Sharma

The U.S. Food and Drug Administration approved the first generic version of Sabril (vigabatrin) 500 mg tablets for treating complex partial seizures, also called focal seizures, as an adjunctive therapy (given with another primary treatment) in patients 10 years and older who have responded inadequately to several alternative (refractory) treatments.

4677 PMBJP Kendras functional in 35 States/UTs of the country by end of year 2018

  • Posted on: 12 January 2019
  • By: Shalini.Sharma

Minister of State for Road Transport and Highways, Shipping and Chemicals and Fertilizers, Shri Mansukh L. Mandaviya, while giving a written reply to a question in Rajya Sabha today, stated that as on 31.12.2018, 4677 ‘Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana’ (PMBJP) Kendras are functional in 35 States/UTs of the country.

The science is clear : with HIV, undetectable equals untransmittable: NIH

  • Posted on: 12 January 2019
  • By: Shalini.Sharma

In recent years, an overwhelming body of clinical evidence has firmly established the HIV Undetectable = Untransmittable (U=U) concept as scientifically sound, say officials from the National Institutes of Health. U=U means that people living with HIV who achieve and maintain an undetectable viral load—the amount of HIV in the blood—by taking and adhering to antiretroviral therapy (ART) as prescribed cannot sexually transmit the virus to others.

Pages